About The Medical Condition Drug Evaluation, FDA Phase III
Find the definition of the medical term Drug Evaluation, FDA Phase III. Drug Evaluation, FDA Phase III defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase III
| Drug Evaluation, FDA Phase III Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase III?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Hospitals, Proprietary ‐ Hospitals owned and operated by a corporation or an individual…
- Myxedemas, Congenital ‐ A condition due to congenital lack of thyroid hormone, marked…
- Ketosuccinates ‐ Salts and esters of…
- Cross Reaction ‐ Serological reactions in which an antiserum against one antigen…
- Venoms, Scorpion ‐ Venoms from animals of the order Scorpionida of the class Arachnida.…
- Neoplasms, Ureter ‐ Cancer or tumors of the URETER. Hematuria, which occurs in 75%…
- Antagonists, Blood Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Carminomicin ‐ A very toxic anthracycline-type antibiotic related to DAUNORUBICIN,…
- Elbow, Tennis ‐ A condition characterized by pain in or near the lateral humeral…
- Tryptan ‐ An essential amino acid that is necessary for normal growth in…